Form D · Other
HYKU BIOSCIENCES INC.
Concord, MA · CIK 0001980518
Offering snapshot reported Aug 13, 2026 · SEC filing
- Reported sold
- $8.61M Offering amount: $8.61M
- Investors reported
- 4 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Jul 30, 2026 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Aug 13, 2026 | Initial | $8,612,446 | No comparison | 4 | SEC filing |
| Jan 2, 2026 | Initial | $6,600,000 | No comparison | 8 | SEC filing |
Offering details
- Securities
- Equity, Option to acquire, Security to be acquired
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-594131
The amount sold includes $3,968,189 through the issuance of stock upon the conversion of outstanding convertible securities.
Source: Form D, filed Aug 13, 2026. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Laura Brass | Director |
| Kleem Chaudhary | Director, Executive |
| John Gustofson | Director |
| Janwillem Naesens | Director |
| Laura Tadvalkar | Director |
| Matthias Van Woensel | Director |
Issuer details
Industry: Other (See others in industry)
Address:
35 Beharrell St.
Concord, MA, 01742
Concord, MA, 01742